1. bookVolume 60 (2022): Edizione 4 (December 2022)
Dettagli della rivista
License
Formato
Rivista
eISSN
2501-062X
Prima pubblicazione
30 Mar 2015
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

The role of Tei index added to the GRACE risk score for prediction of in-hospital MACE after acute myocardial infarction

Pubblicato online: 23 Nov 2022
Volume & Edizione: Volume 60 (2022) - Edizione 4 (December 2022)
Pagine: 222 - 228
Ricevuto: 15 Jul 2022
Dettagli della rivista
License
Formato
Rivista
eISSN
2501-062X
Prima pubblicazione
30 Mar 2015
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

[1] ANTMAN EM. ST-segment elevation myocardial infarction: pathology, pathophysiology, and clinical features. In: Bonow RO, Mann DL, Zipes DP, Libby P, editors. Braunwald’s heart disease a textbook of cardiovascular medicine. Elsevier Saunders; 2012, p. 1087–109.10.1016/B978-1-4377-0398-6.00054-8 Search in Google Scholar

[2] GRANGER CB, GOLBERG RJ, DABBOUS O, PIEPER KS, EAGLE KA, CANNON CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003(163):2345–53.10.1001/archinte.163.19.234514581255 Search in Google Scholar

[3] D’ASCENZO F, BIONDI-ZOCCAI G, MORETTI C, BOLLATI M, OMEDE P, SCIUTO F, et al. TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials 2012;33(3):507–14.10.1016/j.cct.2012.01.00122265976 Search in Google Scholar

[4] WATANABE I, SAITO D, NOIKE R, YABE T, OKUBO R, NAKANISHI R, et al. Measurement of left ventricular end-diastolic pressure improves the prognostic utility of the global registry of acute coronary events score in patients with ST-segment elevation myocardial infarction. Asia Intervention 2019(5):134–40.10.4244/AIJ-D-18-00051 Search in Google Scholar

[5] KATZ AS, HARRIGAN P, PARISI AF. The value and promise of echocardiography in acute myocardial infarction and coronary artery disease. Clinical Cardiology 1992;15(6):401–10.10.1002/clc.49601506031617820 Search in Google Scholar

[6] TEI C, LING LH, HODGE DO, BAILEY KR, OH JK, RODEHEFFER RJ, et al. Combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function–A study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357–66. Search in Google Scholar

[7] EGGERS KM, KEMPF T, VENGE P, WALLENTIN L, WOLLERT KC, LINDAHL B. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. Am Heart J 2010;160(1):88–94.10.1016/j.ahj.2010.05.00220598977 Search in Google Scholar

[8] SEYIS S, OZCAN T. Relationship between Tei index and prognosis in patients with non ST segment elevation myocardial infarction. Arch Clin Case Rep 2017;01(05):259–71.10.26502/acbr.50170030 Search in Google Scholar

[9] KARATZIS EN, GIANNAKOPOULOU AT, PAPADAKIS JE, KARAZACHOS A, NEARCHOU NS. Myocardial performance index (Tei index): evaluating its application to myocardial infarction. Hellenic J Cardiol 2008;50:60–5. Search in Google Scholar

[10] ABUOMARA HZA, HASSAN OM, RASHID T, BARAKA M. Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction. Egypt Heart J 2018;70(2):71–5.10.1016/j.ehj.2017.12.001611236830166885 Search in Google Scholar

[11] ABU-ASSI E, FERREIRA-GONZALEZ I, RIBERA A, MARSAL JR, CASCANT P, HERAS M, et al. “Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?”. Am Heart J 2010;160(5):826-34 e1–3.10.1016/j.ahj.2010.06.05321095268 Search in Google Scholar

[12] SYYLI N, HAUTAMAKI M, ANTILA K, MAHDIANI S, ESKOLA M, LEHTIMAKI T, et al. Left ventricular ejection fraction adds value over the GRACE score in prediction of 6-month mortality after ACS: the MADDEC study. Open Heart 2019;6(1):e001007.10.1136/openhrt-2019-001007660911631328004 Search in Google Scholar

[13] PENCINA M, D’AGOSTINO R, PENCINA K, JANSSENS A, GREENLAND P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 2012;176(6):473–81.10.1093/aje/kws207353034922875755 Search in Google Scholar

[14] COOK N. Quantifying the added value of new biomarkers: how and how not. Diagn Progn Res 2018;2:14.10.1186/s41512-018-0037-2646063231093563 Search in Google Scholar

[15] PEPE M, JANES H, LI C. Net risk reclassification p values: valid or misleading? J Natl Cancer Inst 2014;106(4):dju041.10.1093/jnci/dju041398288924681599 Search in Google Scholar

[16] MUHADI, PRIHARTONO N. Cedera hati hipoksik prediktor komplikasi akut utama pasien infark miokard di unit rawat intensif Koroner Rumah Sakit Cipto Mangunkusumo. Jurnal Penyakit Dalam Indonesia 2018;5:116–22.10.7454/jpdi.v5i3.194 Search in Google Scholar

[17] BIERING-SORENSEN T, MOGELVANG R, JENSEN JS. Prognostic value of cardiac time intervals measured by tissue Doppler imaging M-mode in the general population. Heart 2015;101(12):954–60.10.1136/heartjnl-2014-30713725897041 Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo